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Abstract 
Monocarboxylate Transporter 1 (MCTl) mediates the transport of the main fraction of lactate across the sarcolemma. A common polymor-
phic MCTl variant has been identified, but its role in high intensity exercise performance has not been defined. We investigated the influence 
of MCTl A1470T polymorphism (rsl049434) on lactate accumulation after high intensity circuit training. Ten men aged 20-26 performed 
three controlled circuit training (CWT) sessions at 60%, 70%, and 80% of the 15 repetition maximum (15 RM), in non-consecutive days. 
CWT included three sets of a circuit of eight exercises, obtaining lactate measurements immediately after each set had been completed. Two 
independent variables were analysed: MTC1 genotypes according to the presence or absence of the A1470T polymorphism, and the intensity 
of circuit training. Genotype distributions were in Hardy-Weinberg equilibrium, being 30% wild-type, 50% heterozygotes, and 20% mutated 
homozygotes. Mean lactate concentration at 80% of 15RM were significantly higher than the mean lactate values at the other intensities 
(p < 0.01). Significant differences between genetic groups were found in the lactate accumulation slope at 80% of 15 RM (p = 0.02) and in the 
maximal lactate concentration reached by all subjects in the study (Lmax) (p = 0.03). The carriers of the A1470T polymorphism in the MTC1 
gene seem to exhibit a worse lactate transport capability into the less active muscle cells for oxidation. 
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1. Introduction 
Lactate transport across the sarcolemma is mainly medi-
ated by proton-linked monocarboxylate transporters (MCTl 
and MCT4).1 - 4 In rats, there is a high correlation between 
MCTl expression in muscle and the rate of blood lactate 
clearance.5'6 In humans, expression of MCTl may corre-
lates with lactate removal7 '8 and with the amount of lactate 
oxidised into muscle cells.9 In humans, defects in MCTl 
transporter have been associated with several pathologies. 
Symptoms and signs of muscle injury on exercise and 
heat exposure plus subnormal erythrocyte lactate transport 
have been related with the presence of two mutations in 
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the gene that codifies MCTl . An A1470T polymorphism 
(rs 1049434) in the MCTl gene (resulting in a glutamic acid 
to-aspartic acid change in codon 490), whose physiological 
role is still indeterminate, has been also reported.10 Although 
there appear to be no clinical effects of this polymorphism, 
a 40% reduction of lactate transport rate has been identi-
fied in the erythrocytes of both individuals homozygous and 
heterozygous for this polymorphic variant.10 
In high-intensity exercise, anaerobic metabolism accounts 
for the subsequent lactic accumulation,11 especially in resis-
tance training,12 '13 making it relevant to study this metabolite 
and its movement in the body during strength training. 
We performed a pilot study to investigate the influence of 
the A1470Tpolymorphism (rsl049434) MCTl genotypes on 
lactate accumulation after circuit training. We also examined 
whether the effect of this polymorphism on lactate accumu-
lation depends on the intensity of the circuit training. We 
hypothesised that the A1470T gene polymorphism might lead 
to a reduction in the function of the MCT1 transporter, which 
would be reflected in a greater blood lactate accumulation. 
2. Methods 
Ten men (23.6 ±2.2 years; body mass: 78.2 ±7.0 kg; 
height: 179.2 ± 6.3 cm) gave their written informed consent 
to participate in this study, which was approved by the Human 
Research Review Ethics Committee of the School of Sport 
Sciences, Universidad Politécnica de Madrid. All had at least 
1 year of experience in resistance training for 3-5 h per week, 
were between 20 and 30 years old, physically active and 
non-smokers. Individuals with diabetes, cardiovascular dis-
ease, or other metabolic disorders were excluded from the 
study. 
Percentage body fat was estimated from six skinfolds14: 
triceps, subscapular, suprailium, abdominal, calf, and thigh. 
The following formula were applied: 
%Body fat = (((S6skinfolds) • 0.097) + 3.64) x 100 -1 
Body mass and height were also measured.14 Muscle mass 
(MM) was estimated using Martin's equation15: 
MM (g) = height[0.0553 • (thigh circumference 
- thigh skinfold) • 2 + 0.0987 
• (forearm circumference) • 2 + 0.0331 
• (calf circumference — calf skinfold) • 2] — 2445 
The 15 repetition maximum (15 RM) for each exercise 
included in the circuit weight training (CWT) protocol was 
assessed twice on different days during the two wks prior 
to the CWT sessions, with an intra-class correlation coef-
ficient of 0.870. The subjects came to the laboratory in 
non-consecutive days, assessing each day one of the fol-
lowing exercise groups: leg press and shoulder press; leg 
extensions, cable triceps extensions and lat pull-down; leg 
curl, biceps curl and seated chest press. A standardised warm-
up was performed for 10 min before each assessment,16 and 
all the repetitions were performed at a pre-set rhythm of 1 s 
for the concentric phase and 2 s for the eccentric phase. The 
sounds of a pre-recorded CD ROM indicated this rhythm to 
the subjects. A movement specific warm-up was performed, 
with three sets of 15 repetitions (at 50%, 70%, and 90% of 
the estimated 15RM) with 2 min of recovery between the 
sets. After 5 min of recovery, a final set of 15 repetitions was 
carried at 100% of the estimated 15 RM. If the subject was 
able to perform more than 15 repetitions, another set was 
performed after 5 min, increasing the load of the 15RM of 
2.5%. The load was lowered (-2.5% of 15 RM) if the sub-
ject could not perform 15 repetitions. A maximum of two 
attempts were performed in the same day.17 During the tests, 
all the subjects were verbally encouraged in a standardised 
fashion to perform as many repetitions as possible. 
Participants came to the laboratory in three non-
consecutive days to undergo a CWT session at 60%, 70% 
or 80% of 15RM in a random order. Each session included 
three circuits of eight exercises (seated chest press, leg exten-
sions, lat pull-down, leg press, shoulder press, leg curl, biceps 
curl, and cable triceps extensions), performing 15 repetitions 
in each exercise. Recoveries of 5 min between circuits and 
10 s between exercises were set. Before each session, the 
subject performed a warm up circuit at 20% of their 15 RM. 
Throughout the session, the rhythm at which the exercises 
were performed was the same as the one used in the test-
ing session, and given by the same CD ROM used in the 
preliminary session. 
All of the subjects completed an initial adaptation phase, 
prior to all the testing. This involved the same CWT used 
in the testing sessions, performed three times per week dur-
ing 4 weeks. All the exercises were performed on machines 
(Panatta, Italy). No free weights were used. 
Capillary blood samples were obtained immediately after 
each circuit had been completed, and at minutes 3 and 5 after 
the end of the exercise bout. These samples were analysed by 
enzymatic method using the YSI1500 Sport Analyzer (YSI, 
Yellow Springs, OH, USA), obtaining the lactate concentra-
tions immediately after the first (Lcl), the second (Lc2), and 
the third circuit (Lc3), and at minutes 3 and 5 after the end of 
the exercise bout. Calibrations before and after each session 
were carried according to manufacturer's recommendations. 
Slopes of lactate accumulation (LA) throughout the ses-
sions were obtained by individual linear regression equations. 
First, lactate values were plotted versus time of sampling 
for each subject and intensity. Then, a regression of the 
line obtained was performed, calculating its linear regres-
sion equation. Data of the nine subjects who completed the 
60% and 70% sessions, and at least two circuits of the 80% 
session were included for this calculation. 
To obtain the mean lactate concentration at each inten-
sity (60%, 70% and 80%), lactate concentrations measured 
immediately after each of the three circuits were averaged 
(^ average)- For every subject, the maximal lactate concentra-
tion reached throughout the whole study is reported (Lmax), 
as well as the maximal lactate concentration reached at each 
intensity (LmaxInt). 
Genomic DNA was extracted from peripheral blood using 
a QIAamp DNA Blood Mini kit (QIAGEN, Hilden, Ger-
many). Genomic DNA from the subjects was analysed by 
polymerase chain reaction (PCR) amplification of a frag-
ment containing the A1470T polymorphism of the MCT1 
gene (rs 1049434, exon 5) and following direct sequenc-
ing. The primers used for amplification were as follows10: 
sense primer 5'-ACA CAT ACT GGG CAT GTG GC-3' 
(1455-1474); antisense primer 5'-AAA TCC CAT CAA 
TGA ACA ACT GGT ATG ATT TCC AC-3' (1807-1841). 
PCR reaction was made in a total volume of 50 (iL contain-
ing: 3 (xL genomic DNA, 1.5 mM MgC12,0.2 mM dNTP mix, 
0.4 (xM primer, 4% dimethyl sulfoxide (SIGMA) and 1U Taq 
polymerase (BioTaq Polimerase, BioLine, London, UK). The 
amplification consisted of initial denaturation (94 °C, 5 min); 
35 cycles consisting of denaturation (94 °C, 1 min), annealing 
(55 °C, 1 min), and extension (72 °C, 1 min); and final exten-
sion (72 °C, 10 min). PCR products were electrophoresed on 
1.5% agarose gel to verify successful amplification of the 
387 bp fragments. Prior to sequencing, the PCR products 
were purified using QIAquick PCR Purification Kit (QIA-
GEN, Hilden, Germany). The sequencing reactions were 
carried out using dRhodamine Terminator Cycle Sequenc-
ing Kit (Applied Biosystems, Foster City, CA, USA), and 
analysed on the automated ABI Prism 310 Genetic Analyzer 
(Applied Biosystems, Foster City, CA, USA). The nucleotide 
sequence of exon 5 was obtained from GeneBank (accession: 
NM_003051). 
Subjects were allocated to two groups according to their 
profile of the MCTl gene. Subjects who presented the 
wild-type in their two alleles (AA) were allocated in the 
non-carriers group (NC), and the subjects who presented the 
A1470T polymorphism in at least one of their two alleles (AT 
or TT) were allocated in the carriers group (C). 
Data are presented as mean ± standard deviation (SD). 
Chi-square analysis was used to test for Hardy-Weinberg 
equilibrium. Given the sample size and the variables dis-
tribution, non-parametric tests were used. Two independent 
variables were examined: MTC1 genotype according to the 
presence or absence of the A1470T polymorphism, and CWT 
intensities. Mann Whitney U tests were performed to analyse 
the differences between carrier (C) and non-carrier (NC) of 
the polymorphism for all the lactate variables at each inten-
sity. The mean values for each intensity were compared using 
Friedman ANOVAs for repeated measures from the same 
subjects, followed by Wilcoxon test comparisons. An n of 10 
in each group was adequate for a 0.05 alpha level and provide 
a statistical power of 0.80. 
3. Results 
The genotype distribution (30% wild-type, 50% heterozy-
gotes, 20% mutated homozygotes) showed Hardy-Weinberg 
equilibrium. The allelic frequency was 0.55 and 0.45 
for the wild-type allele and for the polymorphic allele, 
respectively. 
The carriers were 24.1 ±1.3 year old, had a body mass of 
81.2 ± 6.7 kg, and were 180.2 ± 5.1 cm tall. The non-carriers 
were 23.7 ±3.2 year old, had a body mass of 71.2 ±2.5 kg, 
and were 173.6 ±4.2 cm tall. There were no differences in 
the various anthropometric variables, except for body mass 
(p = 0.03). 
The mean lactate concentration at 80% was significantly 
higher that the mean values at the other intensities (p < 0.01) 
(Table 1). 
The Mann-Whitney test showed significant differences in 
the LA slope at 80% of 15 RM between the carriers and non-
Table l 
Main lactate variables measured at 60%, 70% and 80% of 15 RM. 
Lcl (mmolL -1) 
Lc2 (mmolL -1) 
Lc3 (mmolL -1) 
¿average ( m m o l L - 1 ) 
Lmaxlnt (mmolL-1) 
60%(n=10) 
7.1 ± 2.4 
9.5 ± 3.7 
11.3 ± 3.9 
9.3 ± 3.2 
11.5 ± 3.8 
70%(n=10) 
8.7 ± 3.2 
11.0 ± 4.2 
13.0 ± 4.3 
10.9 ± 3.6 
13.8 ± 4.7 
80%(« = 9) 
12.2 ± 3.2 
16.8 ± 3.7 
19.9 ± 5.0 
15.9 ± 3.6* 
19.5 ± 4.7 
Values are means ± SD. Lc 1, lactate concentration immediately after the first 
lap. Lc2, lactate concentration immediately after the second lap. Lc3, lactate 
concentration immediately after the third lap. LaVerage, average of Lcl, Lc2 
and Lc3. Lmaxlnt, maximal lactate concentration observed at each intensity. 
Significant differences with the other intensities, p < 0.01. 
carriers (p = 0.02). Fig. 1 shows the values for the LA slopes 
at the three exercise intensities. 
The test also detected significant differences for Lmax 
(p = 0.03). Lmax occurred after the last circuit at the high-
est intensity they could complete (70% or 80% of 15 RM) 
in all but two subjects. One of them reached it after the last 
60% CWT, and the other at minute 3 after the end of the 
80% CWT. The values of the main lactate variables for both 
genetic groups are shown in Table 2. 
4. Discussion 
We found significant differences between genetic groups 
in the LA slope produced during the 80% CWT, and also 
in the highest lactate concentration value reached during the 
study. 
Merezhinskaya et al. first described the A1470T poly-
morphism of MCTl in patients with deficiency of lactate 
transport.10 There was no clinical relevance of the polymor-
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Fig. 1. Values of the slopes for the lactate accumulation at 60%, 70% and 
80% of 15 RM. *Significant differences with the other intensities, p = 0.03. 
Table 2 
Values of the main lactate variables for non-carriers and carriers. 
¿average (mmolL 
Lmaxlnt (mmolL~ 
¿average (mmolL~ 
Lmaxlnt (mmolL~ 
¿average (mmolL~ 
Lmaxlnt (mmolL~ 
OIL"1) 
' ) 
' ) 
' ) 
' ) 
' ) 
' ) 
C 
8.8 ± 3.2 
11.0 ± 4.1 
10.9 ± 4.0 
14.0 ± 5.2 
16.7 ± 4.1 
21.3 ± 4.7 
21.3 ± 4.1 
NC 
10.5 ± 3.4 
12.8 ± 3.1 
10.9 ± 3.1 
13.3 ± 4.4 
14.3 ± 1.7 
15.8 ± 1.9 
16.3 ± 2.4* 
Values are means ± SD. C, carriers group (heterozygotes plus mutated 
homozygotes). NC, non-carriers group (homozygotes wild-type), ¿average» 
average of the lactate concentrations immediately after each lap. Lmaxlnt, 
maximal lactate concentration observed at each intensity, ¿max, maximal 
lactate concentration observed in the whole study. 
Significant differences between genetic groups, p = 0.03. 
phism, but erythrocyte lactate transport rates were 60-65% 
of normal. We documented a significant difference in the 
lactate accumulation in subjects undergoing maximal effort 
performing high intensity circuit training. 
Previous investigations in humans have shown that 
MCT expression is upregulated after physical training. 
Endurance,18'19 sprint,20'21 and resistance training22'23 
increase from 18%18 to 90%19 the amount of MCTl in 
skeletal muscles. Even one exercise session can produce 
variable changes in MCTs expression,7-24 depending on the 
different timing of the assessment of MCTs expression, with 
decrease of MCTs expression immediately after the exer-
cise session,24 or increase several days after the exercise 
bout.7 We have considered this confounding factor selecting 
our cohort from individuals with similar training experience, 
and including an identical initial adaptation phase for all the 
subjects. 
One of the missense mutations described by Merezhin-
skaya et al. (A>T at coding base 1470) was found in 40 
healthy volunteers, and this polymorphism probably had no 
clinical effect on lactate transport.10 In our study, we found 
this polymorphism in healthy individuals, with an allelic fre-
quency of 0.45. 
The main differences in the interpretation of Merezhin-
skaya et al.10 observations and ours concern the different 
ways used to assess the MCTl function as lactate transporter. 
They measured erythrocyte lactate transporter in vitro, and 
also with an analytic forearm test, the lactate ammonia exer-
cise ratio (LAER) test, modified from the clinical ischemic 
forearm test. In the LAER test, the blood flow through the 
exercising arm is controlled to permit diffusion equilibrium 
between blood and muscle lactate. Despite this control of 
blood flow, the test and the in vitro assay do not reproduce 
the conditions occurring during intense physical exercise, 
where the less active muscles use the lactate as fuel and 
the muscle lactate transporters (MCTl and MCT4) operate 
together.25 
We used high intensity CWT to produce high lactate con-
centrations. We expected that the lactate concentration slope 
would not have been influenced by the training status of our 
subjects or by their muscle mass, as opposed to absolute 
values of lactate concentration. The higher concentrations 
observed in carriers at the end of the CWT session and the 
higher Lmax could be caused by impaired functionality in 
MCTl which would lead to impaired lactate transport into the 
less active muscle cells for oxidation, thus increasing blood 
lactate concentration.4'5 This could increase muscle fatigue, 
given the results of previous studies showing a negative cor-
relation between MCTl content and fatigue indices.8 The 
change in the transporter also could increase the risk of suffer-
ing similar symptoms as those presented in MCTl mutations 
carriers,10 especially in conditions such as very intensity 
training. In our study, the differences between the MCTl 
groups occur only at the highest intensity. Trying to explain 
this lack of difference at lower intensities, we suggest a lac-
tate concentration threshold necessary to observe differences 
between the groups. Under this threshold, the polymorphic 
transporter could cover the required lactate movement, but, if 
the production lactate increases disproportionately, the ability 
of the modified transporter would be insufficient. 
To our knowledge, this is the first study investigating the 
potential influence of MCTl A1470T polymorphism during 
progressively more intense exercise. Potential confounders 
could be the different diet of the subjects, which can influ-
ence substrate utilization and thus lactate production,26-28 
the relatively small, though statistically appropriate, sam-
ple size, the different percentages of muscle fibers among 
the subjects, which determine MCTl expression,23 or the 
fact that we measured blood lactate instead of muscle lactate 
concentration. 
In conclusion, carriers for MCTl A1470T polymorphism 
showed higher lactate accumulations than non-carriers dur-
ing high intensity CWT. Although this observation should be 
considered with caution given our small sample size, these 
results should be taken into account in future studies relat-
ing MCTl expression and lactate transport within exercise.23 
Further research is also required to investigate the impli-
cations of this genetic factor in acid-base balance during 
exercise, and whether these influences are also present in 
women. 
Practical implications 
• Carriers of the MCT1 A1470T polymorphism 
have higher lactate accumulation than non-
carriers during high intensity CWT. 
• This difference in lactate accumulation man-
ifests at high intensity exercise. 
• High intensity resistance training loads could 
be titrated according to the genetic makeup 
of individual athletes. 
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